Insider · CIK 0001555563

Weisman Harlan F

Reports to the SEC for 2 companies · BURLINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001555563

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-07-03	TFF Pharmaceuticals, Inc.A Award	Director, President and CEO	AAward	+27.5K sh	—	—	842,095
2024-07-03	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Director, President and CEO	AAward	+27.5K sh	—	—	27,480
2024-04-18	TFF Pharmaceuticals, Inc.Restricted stock unitsA Award	Director, President and CEO	AAward	+45K sh	—	—	44,967
2023-08-15	TFF Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+600K sh	$0.25	+$150K	814,615
2023-03-10	TFF Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+150K sh	$0.88	+$132K	214,615
2022-12-15	TFF Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+50K sh	$1.06	+$53K	64,615
2022-12-03	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Director, President and CEO	AAward	+1.79M sh	—	—	1,792,450
2022-05-20	TFF Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+4,615 sh	$5.50	+$25.4K	14,615
2022-05-18	TFF Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+2,500 sh	$5.12	+$12.8K	10,000
2022-05-16	TFF Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+2,500 sh	$4.74	+$11.9K	7,500
2020-08-24	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Director, President and CEO	AAward	+20K sh	—	—	159,429
2019-11-29	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Director, President and CEO	AAward	+3,623 sh	—	—	139,429
2019-10-29	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Director, President and CEO	AAward	+43.8K sh	—	—	135,806
2019-10-25	TFF Pharmaceuticals, Inc.P Purchase	Director, President and CEO	PPurchase	+5,000 sh	$5.00	+$25K	5,000
2013-06-20	FBIOFortress Biotech, Inc.P Purchase	Director, Chairman and CEO	PPurchase	+10K sh	$7.59	+$75.9K	30,000
2013-01-14	FBIOFortress Biotech, Inc.P Purchase	Director, Chairman and CEO	PPurchase	+20K sh	$5.71	+$114K	20,000
2013-01-07	FBIOFortress Biotech, Inc. · Options to purchase Common StockA Award	Director, Chairman and CEO	AAward	+1.69M sh	—	—	1,686,590

Recent filings

Accepted (ET)
Jul 84
Weisman Harlan F0001213900-24-059878
SEC(opens sec.gov)
Apr 224
Weisman Harlan F0001213900-24-035077
SEC(opens sec.gov)
Aug 154
Weisman Harlan F0001213900-23-067446
SEC(opens sec.gov)
Mar 134
Weisman Harlan F0001213900-23-019384
SEC(opens sec.gov)
Dec 194
Weisman Harlan F0001213900-22-080672
SEC(opens sec.gov)
Dec 64
Weisman Harlan F0001213900-22-078039
SEC(opens sec.gov)
May 204
Weisman Harlan F0001213900-22-028628
SEC(opens sec.gov)
May 174
Weisman Harlan F0001213900-22-027795
SEC(opens sec.gov)
Aug 264
Weisman Harlan F0001213900-20-023895
SEC(opens sec.gov)
Dec 34
Weisman Harlan F0001213900-19-025251
SEC(opens sec.gov)
Oct 294
Weisman Harlan F0001213900-19-021426
SEC(opens sec.gov)
Jun 214
CORONADO BIOSCIENCES INC0001181431-13-036345
SEC(opens sec.gov)
Jan 154
Weisman Harlan F0001181431-13-003277
SEC(opens sec.gov)
Jan 94
Weisman Harlan F0001181431-13-002658
SEC(opens sec.gov)

Companies

Address

C/O CORONADO BIOSCIENCES, INC. 24 NEW ENGLAND EXECUTIVE PARK

BURLINGTON, MA, 01803